These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18422242)

  • 1. [Paternalism and prenatal diagnosis].
    Högberg U
    Lakartidningen; 2008 Mar 5-11; 105(10):747-8. PubMed ID: 18422242
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined nuchal translucency and biochemistry screening--unanswered questions and moral conflicts].
    Bischofberger E; Gustafson S
    Lakartidningen; 2008 Feb 6-12; 105(6):381-2; author reply 382-3. PubMed ID: 18380359
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical implications of the ethics of informed consent for first-trimester risk assessment for trisomy 21.
    Chervenak FA; McCullough LB; Chasen ST
    Semin Perinatol; 2005 Aug; 29(4):277-9. PubMed ID: 16104682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between nasal bone length and nuchal translucency thickness.
    Maymon R; Levinsohn-Tavor O; Cuckle H; Tovbin Y; Dreazen E; Wiener Y; Herman A
    Prenat Diagn; 2007 Apr; 27(4):387. PubMed ID: 17393558
    [No Abstract]   [Full Text] [Related]  

  • 5. Three stage contingent screening for Down syndrome.
    Huttly WJ; Morris JK; Bestwick JP; Wald NJ; Murphy K; Pandya PP
    Prenat Diagn; 2006 Dec; 26(12):1183; author reply 1184. PubMed ID: 17115454
    [No Abstract]   [Full Text] [Related]  

  • 6. Which contingent sequential screening protocol?
    Wright D; Bradbury I; Benn P; Cuckle H; Ritchie K
    Prenat Diagn; 2005 Jun; 25(6):520-1. PubMed ID: 15966050
    [No Abstract]   [Full Text] [Related]  

  • 7. [Trisomy 21, after a half century].
    Nau JY
    Rev Med Suisse; 2009 Feb; 5(190):380. PubMed ID: 19264068
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antenatal screening for Down syndrome: a smattering of epidemiology].
    Boulvain M; Billieux MH; Irion O
    Rev Med Suisse; 2008 Oct; 4(176):2276-8, 2280. PubMed ID: 19025178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency.
    Bestwick JP; Huttly WJ; Wald NJ
    J Med Screen; 2008; 15(4):204-6. PubMed ID: 19106261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of standardization in determining gestational age for prenatal screening.
    Koster MP; Van Leeuwen-Spruijt M; Wortelboer EJ; Stoutenbeek P; Elvers LH; Loeber JG; Visser GH; Schielen PC
    Ultrasound Obstet Gynecol; 2008 Oct; 32(5):607-11. PubMed ID: 18720453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular biology usefulness for rapid diagnosis of Down's syndrome and common aneuploidies].
    Fauret AL; Bilan F; Patri S; Couet D; Marechaud M; Pierre F; Gilbert-Dussardier B; Kitzis A
    Gynecol Obstet Fertil; 2009; 37(7-8):611-9. PubMed ID: 19574080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apert syndrome associated with increased fetal nuchal translucency.
    Aleem S; Howarth ES
    Prenat Diagn; 2005 Nov; 25(11):1066-7. PubMed ID: 16302163
    [No Abstract]   [Full Text] [Related]  

  • 13. Platyspondylic lethal skeletal dysplasia San Diego type (thanatophoric dysplasia type 1) associated with trisomy 21 presenting with nuchal translucency: a case report.
    Yamada T; Sawai H; Nishimura G; Numabe H; Cho K; Minakami H
    Prenat Diagn; 2009 Jul; 29(7):715-7. PubMed ID: 19340824
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined test + inhibin A at week 13 in contingent sequential testing: an interesting alternative for first-trimester prenatal screening for Down syndrome.
    Ramos-Corpas DJ; Santiago JC
    Prenat Diagn; 2008 Sep; 28(9):833-8. PubMed ID: 18661488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome.
    Amor DJ; Xu JX; Halliday JL; Francis I; Healy DL; Breheny S; Baker HW; Jaques AM
    Hum Reprod; 2009 Jun; 24(6):1330-8. PubMed ID: 19246467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating nuchal translucency scans performed for trisomy screening in a district general hospital between July 1998 and January 2004.
    MacRae R; Ojutiku D; Duke-MacRae J; Usifo F; Ekong M
    J Obstet Gynaecol; 2008 Oct; 28(7):683-7. PubMed ID: 19065360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
    Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ;
    AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis of Pallister-Killian syndrome in two fetuses with increased nuchal translucency.
    Kim MH; Park SY; Kim MY; Lee BY; Lee MH; Ryu HM
    Prenat Diagn; 2008 May; 28(5):454-6. PubMed ID: 18438966
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased fetal nuchal translucency as a sole clue in the prenatal diagnosis of a fetus with trisomy 13.
    Ki KD; Kim SR; Lee WI
    Fetal Diagn Ther; 2009; 26(1):54-6. PubMed ID: 19816033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.